Cite
Extended diagnosis of purine and pyrimidine disorders from urine: LC MS/MS assay development and clinical validation.
MLA
Monostori, Péter, et al. “Extended Diagnosis of Purine and Pyrimidine Disorders from Urine: LC MS/MS Assay Development and Clinical Validation.” PLoS ONE, vol. 14, no. 2, Feb. 2019, pp. 1–17. EBSCOhost, https://doi.org/10.1371/journal.pone.0212458.
APA
Monostori, P., Klinke, G., Hauke, J., Richter, S., Bierau, J., Garbade, S. F., Hoffmann, G. F., Langhans, C.-D., Haas, D., & Okun, J. G. (2019). Extended diagnosis of purine and pyrimidine disorders from urine: LC MS/MS assay development and clinical validation. PLoS ONE, 14(2), 1–17. https://doi.org/10.1371/journal.pone.0212458
Chicago
Monostori, Péter, Glynis Klinke, Jana Hauke, Sylvia Richter, Jörgen Bierau, Sven F. Garbade, Georg F. Hoffmann, Claus-Dieter Langhans, Dorothea Haas, and Jürgen G. Okun. 2019. “Extended Diagnosis of Purine and Pyrimidine Disorders from Urine: LC MS/MS Assay Development and Clinical Validation.” PLoS ONE 14 (2): 1–17. doi:10.1371/journal.pone.0212458.